<DOC>
	<DOC>NCT00447876</DOC>
	<brief_summary>This study will investigate the hypothesis that the analgesic effect of a single injection of Dysport (200 MU) induces a significant reduction of symptoms in chronic cases of plantar fasciitis.</brief_summary>
	<brief_title>Study to Assess the Efficacy and Safety of DysportÂ® in the Treatment of Chronic Plantar Fasciitis</brief_title>
	<detailed_description />
	<mesh_term>Fasciitis</mesh_term>
	<mesh_term>Fasciitis, Plantar</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Chronic plantar fasciitis (duration of disorder at least 4 months) At least 4 points on the visual analogue scale (010) for the most severe pain within the last 48 hours At least 2 previous unsuccessful conservative therapies Age 18 and older Rheumatoid diseases (M. Bechterew, chronic polyarthritis, psoriasisarthritis, para /postinfectious arthritis etc.) Previous surgery in the affected area of the foot Pretreatment with Botulinum toxin A (only de novo patients) Prohibited concomitant treatment: local injections during the study and 2 weeks prior to start of study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>